News

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...
Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.
Hims & Hers Health Inc.’s stock was headed for a record session of losses Monday after pharmaceutical giant Novo Nordisk, ...
Novo, Hims & Hers engage in war of words after Wegovy deal falls apart
Novo Nordisk ended a short-lived agreement to sell its Wegovy weight-loss drug through Hims & Hers Health on Monday, sending ...
Novo sends Hims packing
Meanwhile, Novo had agreed supply deals with Hims and several of its larger rivals. The idea was to give their existing ...
Money Morning2h
Hims Stock in Freefall: Read This Before Buying
First, the stock has sliced through two support levels. Shares broke through their 50-day moving average on Monday for the ...
Zacks.com on MSN1h
HIMS Stock Crashes 30% in a Day: Time to Buy the Dip?
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Top Stock Movers Now: Tesla, Hims & Hers, Wolfspeed, and More
U.S. equities were higher at midday as concerns oil prices would spike because of the U.S. attack on Iran diminished.